EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

L467F;F508del Complex Allele in a Heterozygous State with CFTRdele2,3: What to Expect from CFTR Modulators?

Elena Kondratyeva iD, Anna Efremova iD, Yuliya Melyanovskaya iD, Maria Krasnova iD, Michael Milovanov, Olga Shchagina iD, Anna Stepanova iD, Anna Voronkova iD, Victoria Sherman iD, Sergey Kutsev iD, Dmitry Goldshtein iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311742 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Elena Kondratyeva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis, Mutation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CFTR modulators have significantly affected the prognosis for cystic fibrosis, improving the clinical course in most patients with the F508del variant and several other CFTR gene variants. The presence of complex alleles, including more than one variant in the cis position, can change the properties of the protein and the efficacy of modulators. Objective: We aimed to describe the efficacy of CFTR modulators in the treatment of two siblings with the c.[1521_1523delCTT;1399C>T];[54-5940_273+10250del21kb] (L467F;F508del/CFTRdele2,3) genotype in clinical practice and in vitro. This article presents the clinical presentation and results of CFTR channel function assessment and personalized selection of CFTR modulators in monochorionic diamniotic twins with cystic fibrosis and the L467F;F508del/CFTRdele2,3 genotype. This is the first demonstration of the efficacy of a new CFTR modulator in patients with a complex allele and a class I variant in the genotype. The obtained results may be useful for choosing treatment strategies for patients with a complex allele and a class I variant in the genotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorCystic FibrosisMutationHumansAllelesHeterozygoteMaleFemaleGenotype

Stichwörter der Autor:innen

CFTR geneF508delL467Fcomplex allelecystic fibrosisintestinal current measurementintestinal organoidspancreatitistargeted therapy

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorCFTR protein, human

Autor:innen und Institutionen

  • Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia.

ORCID-Profile: Elena Kondratyeva, Anna Efremova, Yuliya Melyanovskaya, Maria Krasnova, Olga Shchagina, Anna Stepanova, Anna Voronkova, Victoria Sherman, Sergey Kutsev, Dmitry Goldshtein

Förderung

  • Russian Science Foundation

Zitieren

APA

Kondratyeva, E., Efremova, A., Melyanovskaya, Y., Krasnova, M., Milovanov, M., Shchagina, O., Stepanova, A., Voronkova, A., Sherman, V., Kutsev, S., & Goldshtein, D. (2025). L467F;F508del Complex Allele in a Heterozygous State with CFTRdele2,3: What to Expect from CFTR Modulators?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311742

Vancouver

Kondratyeva E, Efremova A, Melyanovskaya Y, Krasnova M, Milovanov M, Shchagina O, et al. L467F;F508del Complex Allele in a Heterozygous State with CFTRdele2,3: What to Expect from CFTR Modulators?. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311742

BibTeX
@article{Kondratyeva2025,
  author = {Kondratyeva, Elena and Efremova, Anna and Melyanovskaya, Yuliya and Krasnova, Maria and Milovanov, Michael and Shchagina, Olga and Stepanova, Anna and Voronkova, Anna and Sherman, Victoria and Kutsev, Sergey and Goldshtein, Dmitry},
  title = {L467F;F508del Complex Allele in a Heterozygous State with CFTRdele2,3: What to Expect from CFTR Modulators?},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311742}
}
Kostenlos starten →